Definitive Contract 75F40118C50065

Award Date 9/14/18
Potential Completion Date 3/23/23
Potential Value $429K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Columbus, OH 43210, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $833,004 firm-fixed-price contract to The Ohio State University to provide training facilities, qualified instructors, audiovisual support equipment, and pilot processing laboratories to deliver the FDA's Food Processing and Technology Course (FD 152). This course is part of the FDA's manufactured food curriculum for training federal, state, local, and tribal investigators/inspectors to conduct regulatory inspections. The contract has an...
This federal contract award in the amount of $97,584.97 was issued by the Food and Drug Administration (FDA) to The Ohio State University. The award is part of the OARSA CONSORTIUM and has a period of performance ending on September 30, 2017. The contract is a firm fixed-price purchase order and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $963,253.00 firm fixed price purchase order contract to The Ohio State University for research on "Foodborne Pathogens in Small Specialty Farming Produce and Transduction of Antimicrobial Resistance Genes in Agricultural Systems." The contract, which does not have a set-aside designation, runs through September 29, 2024. As a public research university, The Ohio State University has a history...
This is a definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to The Ohio State University for the "OHIO STATE ORGANISMS & GENES STUDY." The contract, which does not have a set-aside designation, was awarded on September 30, 2018 with a potential value of $385,853.00 and a completion date of December 31, 2019. As a public research university, The Ohio State University has a history of...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration to The Ohio State University on September 4, 2018 with a potential value of $158,623.00 and a completion date of November 30, 2019. The contract is for the "OSU CONSORTIUM FOR OARSA" and does not have a set-aside designation. As a public research university, The Ohio State University has a history of providing various goods and services to federal...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a definitive cost-no-fee contract valued at $693,598.00 to The Ohio State University (OSU) on September 29, 2017. The contract, which does not have a set-aside designation, is for unspecified "other functions" and is scheduled for completion on March 31, 2019. OSU, through its Office of Sponsored Programs, has previously provided various goods and services to federal agencies,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $234,400.00 firm fixed price purchase order to The Ohio State University for the testing of gnotobiotic piglets. The contract has a completion date of December 31, 2022 and was awarded on July 23, 2020. The Ohio State University is a public research university that has a history of providing various goods and services to federal agencies through prime contracts and subcontracts, including...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Ohio State University in the amount of $630,103.00. The contract has a firm fixed price pricing type and a completion date of April 30, 2023. It was awarded on August 1, 2020 and does not have a set-aside designation. The contract is for FY20 BAA TOPIC 5.5 and the place of performance is Chamblee, Georgia. The Ohio State University is a public research university...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to The Ohio State University in the amount of $110,250.00 to provide a 5-day workshop on immersion evidence-based training for 147 employees. The contract has a completion date of September 30, 2021 and does not have a set-aside designation. The Ohio State University is a public research university that has previously provided various services to federal agencies through prime contracts...
This is a firm fixed-price purchase order contract awarded by the Washington Headquarters Service, a defense agency, to The Ohio State University in the amount of $123,636.00. The contract is for graduate research support services and does not have a set-aside designation. The Ohio State University has a history of providing various goods and services to federal agencies, including coordination and support services for clinical trials related to women's health, infrastructure support for NASA...

The Ohio State University was awarded a firm fixed price definitive contract valued at $429,098.39 by the Department of Health and Human Services' Food and Drug Administration to provide training and pilot processing laboratory facility services in Columbus, Ohio. The contract has a period of performance through March 2023 to support the FDA's Office of Training Education and Development in delivering processing technology courses. No set-aside designation was used for this award made under an indefinite delivery contract held by The Ohio State University to serve as a Women's Health Initiative Regional Center for the National Institutes of Health National Heart, Lung and Blood Institute through October 2028.

Generated 2/28/24, 9:58 AM